GeneDx Holdings (WGS) Inventory Average (2021 - 2026)

GeneDx Holdings (WGS) has reported Inventory Average for 6 consecutive years, with $13.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory Average rose 12.35% year-over-year to $13.1 million; the TTM figure through Mar 2026 stood at $13.1 million (up 12.35% YoY), while the FY2025 annual figure was $12.3 million, up 26.63% from the prior year.
• Inventory Average grew to $13.1 million in Q1 2026 per WGS's latest filing, from $12.3 million in the prior quarter.
• Across five years, Inventory Average topped out at $42.9 million in Q3 2022 and bottomed at $9.1 million in Q4 2023.
• Historically, Inventory Average has averaged $17.2 million across 5 years, with a median of $11.9 million in 2023.
• Annual changes were most pronounced in 2022 — Inventory Average jumped 42.24% — and 2023, when it plunged 75.66%.
• GeneDx Holdings' Inventory Average stood at $28.9 million in 2022, then tumbled by 68.66% to $9.1 million in 2023, then climbed by 18.17% to $10.7 million in 2024, then climbed by 14.47% to $12.3 million in 2025, then climbed by 6.82% to $13.1 million in 2026.
• Business Quant data shows WGS's Inventory Average at $13.1 million in Q1 2026, $12.3 million in Q4 2025, and $11.3 million in Q3 2025.